Immuron Ltd Files October 2024 6-K Report
Ticker: IMRN · Form: 6-K · Filed: Oct 18, 2024 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Oct 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
Related Tickers: IMRN
TL;DR
Immuron Ltd (IMRN) filed its October 6-K, no 12g3-2(b) info, just standard foreign issuer update.
AI Summary
Immuron Limited filed a Form 6-K on October 18, 2024, reporting on its activities for the month of October 2024. The filing indicates that the company is a foreign private issuer and is not furnishing information under Rule 12g3-2(b). The report is filed under the 1934 Act with commission file number 001-38104.
Why It Matters
This filing provides an update on Immuron Limited's regulatory disclosures for October 2024, which is important for investors tracking the company's compliance and reporting status.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer activities and does not contain significant new financial or operational information that would inherently increase risk.
Key Numbers
- 001-38104 — SEC File Number (Identifies Immuron Limited's filing with the SEC.)
Key Players & Entities
- Immuron Limited (company) — Registrant
- 001-38104 (company) — SEC File Number
- October 18, 2024 (date) — Filing Date
FAQ
What type of report is Immuron Limited filing?
Immuron Limited is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What is the Commission File Number for Immuron Limited?
The Commission File Number for Immuron Limited is 001-38104.
Does Immuron Limited file annual reports under Form 20-F or 40-F?
Yes, Immuron Limited indicates it files annual reports under cover of Form 20-F.
Is Immuron Limited furnishing information under Rule 12g3-2(b)?
No, Immuron Limited is not furnishing information to the Commission pursuant to Rule 12g3-2(b).
What is the principal executive office address for Immuron Limited?
The principal executive office address for Immuron Limited is Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Filing Stats: 310 words · 1 min read · ~1 pages · Grade level 18.4 · Accepted 2024-10-18 06:06:28
Filing Documents
- ea0217980-6k_immuron.htm (6-K) — 12KB
- ea021798001ex99-1_immuron.htm (EX-99.1) — 436KB
- ex99-1_001.jpg (GRAPHIC) — 543KB
- ex99-1_002.jpg (GRAPHIC) — 860KB
- 0001213900-24-088659.txt ( ) — 2381KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of October 2024 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on October 18, 2024 titled: - “Notice of Annual General Meeting” A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Notice of Annual General Meeting 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: October 18, 2024 By: /s/ Phillip Hains Phillip Hains Company Secretary 3